Press Release | Tue Aug 27, 2013 10:42pm EDT

Studies of Nanoliposomal Irinotecan (PEP02, MM-398) in Late Stage Pancreatic Cancer and Gastric Cancer Published in British Journal of Cancer and Annals of Oncology<4162.TWO>

* Reuters is not responsible for the content in this press release.